Clec4A4 作为一个负免疫检查点调节剂,抑制抗瘤免疫力
Tomofumi Uto1,2, Tomohiro Fukaya1,2, Shuya Mitoma1,2
1Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Cancer immunology research
|July 11, 2023
概括
鼠类Clec4A4 (mClec4A4) 通过损害树突细胞 (cDC) 激活来负面调节抗瘤免疫力. 通过增强抗瘤反应,阻断其人类正方形 (hCLEC4A) 对癌症免疫疗法有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 树突细胞生物学 树突细胞生物学
背景情况:
- 克莱克4A4是一种C型乳素受体 (CLR),存在于小鼠常规树突细胞 (cDCs) 上.
- 它在抗瘤免疫力中的确切作用尚未完全理解.
- 了解Clec4A4的功能对于开发新型癌症免疫疗法至关重要.
研究的目的:
- 研究小鼠Clec4A4 (mClec4A4) 在抗瘤免疫中的功能作用.
- 为了确定mClec4A4是否作为抗瘤免疫反应的负调节剂.
- 评估在癌症免疫疗法中准其人类正经体,hCLEC4A的治疗潜力.
主要方法:
- 使用了缺乏mClec4A4.4.的淘汰赛小鼠模型.
- 在体内评估瘤发育和免疫细胞激活.
- 在转基因小鼠中对人类CLEC4A (hCLEC4A) 进行了对抗性单克隆抗体 (mAbs) 的治疗.
- 监测瘤进展和潜在的免疫相关不良事件.
主要成果:
- mClec4A4 缺乏导致瘤生长减少.
- 缺乏mClec4A4增强了抗瘤免疫反应,并改善了瘤微环境 (TME).
- 在hCLEC4A转基因小鼠中,对抗性抗hCLEC4A mAb治疗对已建立的瘤进行了保护,没有副作用.
结论:
- mClec4A4作为一个负免疫检查点调节器,抑制抗瘤免疫力.
- 用对抗性抗体向hCLEC4A是癌症免疫疗法中免疫检查点阻塞的一个有希望的策略.
- 这些发现支持hCLEC4A作为增强抗瘤反应的潜在治疗点.
相关概念视频
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K


